相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
Stacy B. Menees et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes
J. Bonneau et al.
AUTOIMMUNITY REVIEWS (2015)
XIAP deficiency syndrome in humans
Sylvain Latour et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Significance of low level infliximab in the absence of anti- infliximab antibodies
Bella Ungar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Treatment of IBD: Where We Are and Where We Are Going
Charles N. Bernstein
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future
Lieke M. Spekhorst et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
The role and advances of immunomodulator therapy for inflammatory bowel disease
Ole Haagen Nielsen et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Paul Henderson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial
Casper Steenholdt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
Xavier Roblin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Optimizing anti-TNF treatments in inflammatory bowel disease
Shomron Ben-Horin et al.
AUTOIMMUNITY REVIEWS (2014)
Mutations in Tetratricopeptide Repeat Domain 7A Result in a Severe Form of Very Early Onset Inflammatory Bowel Disease
Yaron Avitzur et al.
GASTROENTEROLOGY (2014)
Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations
Suk-Kyun Yang et al.
GUT (2014)
Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease
Kaija-Leena Kolho et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon
Adam M. Zahm et al.
JOURNAL OF CROHNS & COLITIS (2014)
Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment
Per Marits et al.
JOURNAL OF CROHNS & COLITIS (2014)
Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort
Keiichi Mitsuyama et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab
Shin Fujioka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Advances in IBD genetics
Johan Van Limbergen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Chromogranin A as a marker of disease activity in inflammatory bowel disease
Ibrahim Koral Onal et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study
Athanasios Zissimopoulos et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Intestinal antigen-presenting cells in mucosal immune homeostasis: Crosstalk between dendritic cells, macrophages and B-cells
Elizabeth R. Mann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Metalloproteinase-3 and-9 as Novel Markers in the Evaluation of Ulcerative Colitis Activity in Children
Anna Kofla-Dlubacz et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2014)
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
R. Khanna et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
Kavinderjit S. Nanda et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
Niels Vande Casteele et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn's disease
Francis Vasseur et al.
BMC MEDICAL GENETICS (2013)
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease
M. Iborra et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease
Maria Teresa Arias-Loste et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Association Between Variants of PRDM1 and NDP52 and Crohn's Disease, Based on Exome Sequencing and Functional Studies
David Ellinghaus et al.
GASTROENTEROLOGY (2013)
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
Nicholas T. Ventham et al.
GASTROENTEROLOGY (2013)
Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing
Darrell L. Dinwiddie et al.
GENOMICS (2013)
Serological markers predict inflammatory bowel disease years before the diagnosis
Fiona D. M. van Schaik et al.
GUT (2013)
Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes
Katja Christodoulou et al.
GUT (2013)
Mechanisms of Action of Anti-tumor Necrosis Factor a Agents in Crohn's Disease
Simon T. C. Peake et al.
INFLAMMATORY BOWEL DISEASES (2013)
Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies: A Marker of Aggressive Crohn's Disease
Grace Gathungu et al.
INFLAMMATORY BOWEL DISEASES (2013)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2013)
Serum Adalimumab Concentration and Clinical Remission in Patients with Crohn's Disease
Yi-Lin Chiu et al.
INFLAMMATORY BOWEL DISEASES (2013)
Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases
Stephane Nancey et al.
INFLAMMATORY BOWEL DISEASES (2013)
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
Martine De Vos et al.
INFLAMMATORY BOWEL DISEASES (2013)
Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
Stephane Paul et al.
INFLAMMATORY BOWEL DISEASES (2013)
Fecal MMP-9: A New Noninvasive Differential Diagnostic and Activity Marker in Ulcerative Colitis
Anita Annahazi et al.
INFLAMMATORY BOWEL DISEASES (2013)
MicroRNA-132 Modulates Cholinergic Signaling and Inflammation in Human Inflammatory Bowel Disease
Nitsan Maharshak et al.
INFLAMMATORY BOWEL DISEASES (2013)
IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis
Christopher J. Moran et al.
INFLAMMATORY BOWEL DISEASES (2013)
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel
Valerie Pittet et al.
JOURNAL OF CROHNS & COLITIS (2013)
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
Pauline A. van Schouwenburg et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
DNA methylation in inflammatory bowel disease and beyond
Daren Low et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases
Sara De Iudicibus et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Mucosal healing and deep remission: What does it mean?
Gerhard Rogler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Impact of exome sequencing in inflammatory bowel disease
Christopher J. Cardinale et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis
Melissa Beaudoin et al.
PLOS GENETICS (2013)
Correlation of MMP-3 and MMP-9 with Crohn's Disease Activity in Children
Anna Kofla-Dlubacz et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
The Age of Gene Discovery in Very Early Onset Inflammatory Bowel Disease
Aleixo M. Muise et al.
GASTROENTEROLOGY (2012)
Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy
Daniel Kotlarz et al.
GASTROENTEROLOGY (2012)
Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment
N. Vande Casteele et al.
GUT (2012)
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease
Takahiro Inoue et al.
INFLAMMATORY BOWEL DISEASES (2012)
Therapeutic drug monitoring of biologics for inflammatory bowel disease
Jean-Frederic Colombel et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
Pauliina Molander et al.
INFLAMMATORY BOWEL DISEASES (2012)
Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis
Amit Kaul et al.
INFLAMMATORY BOWEL DISEASES (2012)
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
Satoshi Serada et al.
INFLAMMATORY BOWEL DISEASES (2012)
miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes
Joel R. Pekow et al.
INFLAMMATORY BOWEL DISEASES (2012)
Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies
Uri Kopylov et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
Ren Mao et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Circulating MicroRNA in inflammatory bowel disease
Archanioti Paraskevi et al.
JOURNAL OF CROHNS & COLITIS (2012)
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
M. De Vos et al.
JOURNAL OF CROHNS & COLITIS (2012)
Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
Hirotsugu Imaeda et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum
Shui-Long Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
The gut microbiota in IBD
Chaysavanh Manichanh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis
Radha Duttagupta et al.
PLOS ONE (2012)
MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics
Mehmet Coskun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease
T. Aomatsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Review article: loss of response to anti-TNF treatments in Crohn's disease
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Fecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel Disease
Roberta Vitali et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease
Dirk Roggenbuck et al.
CLINICA CHIMICA ACTA (2011)
Isolation and characterization of a novel short peptide associated with Crohn's disease
K. Mitsuyama et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease
Elizabeth A. Worthey et al.
GENETICS IN MEDICINE (2011)
The immunogenic part of infliximab is the F(ab ')(2), but measuring antibodies to the intact infliximab molecule is more clinically useful
Shomron Ben-Horin et al.
GUT (2011)
Peripheral Blood MicroRNAs Distinguish Active Ulcerative Colitis and Crohn's Disease
Feng Wu et al.
INFLAMMATORY BOWEL DISEASES (2011)
Dynamic Changes in the Expression of MicroRNA-31 During Inflammatory Bowel Disease-associated Neoplastic Transformation
Alexandru V. Olaru et al.
INFLAMMATORY BOWEL DISEASES (2011)
Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis
Zhen Bian et al.
JOURNAL OF PATHOLOGY (2011)
Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease
Adam M. Zahm et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease
Patrick Brest et al.
NATURE GENETICS (2011)
Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Soluble ST2: A new and promising activity marker in ulcerative colitis
David Diaz-Jimenez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases
Satoshi Serada et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
C. H. Seow et al.
GUT (2010)
Mucosal Healing as an Index of Colitis Activity: Back to Histological Healing for Future Indices
Burton I. Korelitz
INFLAMMATORY BOWEL DISEASES (2010)
Identification of MicroRNAs Associated with Ileal and Colonic Crohn's Disease
Feng Wu et al.
INFLAMMATORY BOWEL DISEASES (2010)
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
Charles N. Bernstein et al.
INFLAMMATORY BOWEL DISEASES (2010)
MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell Differentiation
Hang Thi Thu Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis
Tomohisa Takagi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation
Shane Crotty et al.
NATURE IMMUNOLOGY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mucosal biomarkers in inflammatory bowel disease: Key pathogenic players or disease predictors?
Franco Scaldaferri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Patrick F. van Rheenen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype
Cynthia H. Seow et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Applications of Proteomics in the Study of Inflammatory Bowel Diseases: Current Status and Future Directions with Available Technologies
Philip Alex et al.
INFLAMMATORY BOWEL DISEASES (2009)
Plasma Chromogranin A in Patients with Inflammatory Bowel Disease
Valentina Sciolo et al.
INFLAMMATORY BOWEL DISEASES (2009)
Finding the missing heritability of complex diseases
Teri A. Manolio et al.
NATURE (2009)
Targeted capture and massively parallel sequencing of 12 human exomes
Sarah B. Ng et al.
NATURE (2009)
NDP52: the missing link between ubiquitinated bacteria and autophagy
Stanimir Ivanov et al.
NATURE IMMUNOLOGY (2009)
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Erik-Oliver Glocker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
XIAP mediates NOD signaling via interaction with RIP2
Andreas Krieg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The gut microbiota shapes intestinal immune responses during health and disease
June L. Round et al.
NATURE REVIEWS IMMUNOLOGY (2009)
IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease
Shinichiro Shinzaki et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa*
W. Stöcker et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers?
William J. Sandborn
GASTROENTEROLOGY (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
The impact of microRNAs on protein output
Daehyun Baek et al.
NATURE (2008)
New serological biomarkers of inflammatory bowel disease
Xuhang Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The genetics and immunopathogenesis of inflammatory bowel disease
Judy H. Cho
NATURE REVIEWS IMMUNOLOGY (2008)
IBD serological panels: Facts and perspectives
Lourent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2007)
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
T. Kaiser et al.
GUT (2007)
Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation
Guy Chung-Faye et al.
INFLAMMATORY BOWEL DISEASES (2007)
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
Marc Ferrante et al.
GUT (2007)
Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype
M. J. W. Meijer et al.
DIGESTIVE AND LIVER DISEASE (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease
Steven T. Leach et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Relationship between fecal lactoferrin and inflammatory bowel disease
Jun Dai et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
Elana A. Maser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Role of matrix metalloproteinases in intestinal inflammation
Carlos Medina et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease
Iris Dotan et al.
GASTROENTEROLOGY (2006)
Fecal S100A12: A novel noninvasive marker in children with Crohn's disease
Naomi S. H. de Jong et al.
INFLAMMATORY BOWEL DISEASES (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
L Agostini et al.
IMMUNITY (2004)
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
WS Mow et al.
GASTROENTEROLOGY (2004)
Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease
DG Forcione et al.
GUT (2004)
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype
IDR Arnott et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Incidence and Importance of Antibody Responses to Infliximab After Maintenance or Episodic Treatment in Crohn's Disease
Stephen B. Hanauer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Serologic testing with ANCA, ASCA, and anti-ompC in children and young adults with Crohn's disease and ulcerative colitis: Diagnostic value and correlation with disease phenotype
A Zholudev et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Assembly of the phagocyte NADPH oxidase
WM Nauseef
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Bacterial flagellin is a dominant antigen in Crohn disease
MJ Lodes et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Intracellular and extracellular roles of s100 proteins
R Donato
MICROSCOPY RESEARCH AND TECHNIQUE (2003)
Mechanisms of disease - The chromogranin-secretogranin family.
L Taupenot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of serum soluble ST2 receptor as a novel heart failure biomarker
EO Weinberg et al.
CIRCULATION (2003)
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease
I Vind et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease
E Louis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
分享论文
